Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesUrinary estrogen metabolites in women at high risk for breast cancer
Carcinogenesis, 09/03/09
Im A et al. – This study suggests that lower urinary 2:16 OHE ratios are predictors of breast cancer risk. Profiling estrogen metabolites may identify women who are more probably to develop breast cancer within a population of women with known risk factors and may help to further elucidate the clinical relevance of urinary 2:16 OHE ratios as clinical markers and prognostic indicators in this population.
Related Articles
Estrone/17[beta]-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis
Arthritis & Rheumatism, 10/01/09
Relevance Score: 70%
Serum Estrogen Metabolites and Systolic Blood Pressure Among Middle-Aged and Older Women and Men
American Journal of Hypertension, 10/28/09
Relevance Score: 64%
Hormone Mix Could Cut Breast Cancer Risk And Treat Symptoms Of Menopause
ScienceDaily, 10/21/09
Relevance Score: 45%
Hormone mix could cut breast cancer risk and treat symptoms of menopause
EurekAlert, 10/20/09
Relevance Score: 45%
Cross-Talk between Estrogen Receptor and Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research, 10/19/09
Relevance Score: 45%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
The effect of magnetic resonance imaging in the workup of breast cancer
The American Journal of Surgery, 12/14/09
Breast Cancer in Young Women in a Limited-Resource Environment
World Journal of Surgery, 12/14/09
A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo
The American Journal of Surgery, 12/12/09
Sponsor
Article Search
Sponsor
Sponsor